標(biāo)題: Titlebook: Alternating Electric Fields Therapy in Oncology; A Practical Guide to Eric T. Wong Book 2016 Springer International Publishing Switzerland [打印本頁] 作者: Autonomous 時(shí)間: 2025-3-21 19:46
書目名稱Alternating Electric Fields Therapy in Oncology影響因子(影響力)
書目名稱Alternating Electric Fields Therapy in Oncology影響因子(影響力)學(xué)科排名
書目名稱Alternating Electric Fields Therapy in Oncology網(wǎng)絡(luò)公開度
書目名稱Alternating Electric Fields Therapy in Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Alternating Electric Fields Therapy in Oncology被引頻次
書目名稱Alternating Electric Fields Therapy in Oncology被引頻次學(xué)科排名
書目名稱Alternating Electric Fields Therapy in Oncology年度引用
書目名稱Alternating Electric Fields Therapy in Oncology年度引用學(xué)科排名
書目名稱Alternating Electric Fields Therapy in Oncology讀者反饋
書目名稱Alternating Electric Fields Therapy in Oncology讀者反饋學(xué)科排名
作者: 彩色 時(shí)間: 2025-3-21 22:02
Fundamental Physics of Tumor Treating Fields,. Recently, the anticancer Tumor Treating Fields (TTFields), which are alternating electric fields applied according to the principles of Maxwell’s equations of electromagnetism, has made available a novel method of treating patients with glioblastomas, brain metastases, and certain systemic maligna作者: ALERT 時(shí)間: 2025-3-22 03:21
Biophysical Effects of Tumor Treating Fields, theoretical investigations lead to numerous cell characterization and manipulation techniques which were translated into clinical applications. Low-frequency alternating current (AC) fields are employed for nerve and muscle stimulation, while high-frequency fields find medical relevance in tissue h作者: 蒙太奇 時(shí)間: 2025-3-22 07:26
Computer Simulation of Tumor Treating Fields,ents. TTFields are alternating electric fields at 200 kHz continuously delivered by the Optune device to the scalp of patients. Preclinical experiments have shown that they interfere with dividing cancer cells as they undergo metaphase-to-anaphase transition in mitosis and, specifically, they disrup作者: 恃強(qiáng)凌弱 時(shí)間: 2025-3-22 09:49
Response Pattern and Modeling of Tumor Treating Fields,. The Optune device represents an innovative treatment option for patients with recurrent GBM, which utilizes alternating electric fields at an intermediate frequency of 200 kHz, or Tumor Treating Fields (TTFields), to selectively kill or arrest the growth of rapidly dividing cells. Approximately 15作者: 令人悲傷 時(shí)間: 2025-3-22 14:47
Clinical Efficacy of Tumor Treating Fields for Recurrent Glioblastoma, criteria but the extent of the tumor is much larger than that can be seen on neuroimaging. Patient prognosis is poor and survival is short. The Optune device is an FDA-approved treatment for recurrent glioblastoma and it uses Tumor Treating Fields (TTFields) to disrupt tumor cells as they undergo m作者: cardiopulmonary 時(shí)間: 2025-3-22 20:28 作者: 最小 時(shí)間: 2025-3-23 00:22
Tumor Treating Fields Therapy for Newly Diagnosed Glioblastoma, within the tumor microenvironment. These inter-tumoral and intra-tumoral heterogeneities are what make glioblastomas so difficult to treat in patients. As the tumor progresses over time, it accumulates more alterations and co-opts normal physiological processes for growth and proliferation as well 作者: 閑逛 時(shí)間: 2025-3-23 04:33 作者: 惰性女人 時(shí)間: 2025-3-23 07:08
Future Directions for Tumor Treating Fields,d glioblastoma since receiving FDA approvals in 2011 and 2015, respectively. Where this treatment modality goes from here is currently a subject of intensive clinical investigations. For glioblastoma, TTFields are being combined with stereotactic radiosurgery, hypofractionated radiation, bevacizumab作者: 酷熱 時(shí)間: 2025-3-23 13:14
Book 2016uded, as well as some ofthe ancillary .post hoc. analyses thatwere performed by variousinvestigators. The remainder of the chapter covers other solid tumormalignancies, including non-small cell lung cancer, pancreatic cancer andovarian cancer, as this treatment modality is being applied to systemicm作者: 公式 時(shí)間: 2025-3-23 16:24
estigators. The remainder of the chapter covers other solid tumormalignancies, including non-small cell lung cancer, pancreatic cancer andovarian cancer, as this treatment modality is being applied to systemicm978-3-319-80840-6978-3-319-30576-9作者: PIZZA 時(shí)間: 2025-3-23 19:59 作者: thrombosis 時(shí)間: 2025-3-23 22:52 作者: dialect 時(shí)間: 2025-3-24 03:56 作者: 流逝 時(shí)間: 2025-3-24 10:12 作者: Incorruptible 時(shí)間: 2025-3-24 12:06
https://doi.org/10.1007/978-3-642-91369-3e reversing and regressing in size, at a median time of 4 months. Tumor responses develop gradually and initial tumor growth may be observed even in eventual responders. Thus, we recommend that TTFields should be continued for a sufficient amount of time and that initial radiologic progression follo作者: 歪曲道理 時(shí)間: 2025-3-24 16:43
https://doi.org/10.1007/978-3-642-91369-3with the device were grade 1 or 2 scalp dermatitis, and shifting of the arrays slightly during array change and applying topical corticosteroid can minimize this irritation. There were far less hematological and gastrointestinal toxicities when compared to chemotherapy. In . analyses of EF-11, secon作者: 空洞 時(shí)間: 2025-3-24 19:55 作者: 天文臺(tái) 時(shí)間: 2025-3-25 00:09
Diagnostik der Farbensinnst?rungends together with maintenance temozolomide when compared to those treated with temozolomide alone. The median progression free survival was 7.1 (95 % CI 5.9–8.2) months in the TTFields plus temozolomide cohort and 4.0 (95 % CI 3.3–5.2) months in the temozolomide alone cohort (hazard ratio = 0.62 [95 作者: 痛恨 時(shí)間: 2025-3-25 07:12
,Formver?nderung der H?nde und Fü?e,s into a better quality of life, which is an important parameter in cancer treatment. Past clinical trials in recurrent glioblastoma has shown that global health scale, emotional functioning, and role functioning domains are superior among subjects treated with TTField monotherapy when compared to c作者: perpetual 時(shí)間: 2025-3-25 07:46
Diagnostik der Kinderkrankheiten1 trial for non-small cell lung cancer brain metastasis is currently recruiting subjects in Europe and the METIS or EF-25 trial is now open in the United States. These studies will provide efficacy data on TTFields for other types of central nervous system tumors. Lastly, extracranial application of作者: Irrepressible 時(shí)間: 2025-3-25 14:55
Cell Biological Effects of Tumor Treating Fields, structures within the cytokinetic cleavage furrow and crosslinks actin bundles in the submembranous cytoskeleton which restrains the hydrostatic pressure produced by furrow ingression. TTFields perturb Septin localization to the anaphase spindle midline and cytokinetic furrow. TTField exposure lead作者: 不能逃避 時(shí)間: 2025-3-25 16:51
Fundamental Physics of Tumor Treating Fields,he alternating characteristics of TTFields are driven by changing electric potentials, and the distribution of these fields is dependent on tissue characteristics, such as electric conductivity and relative permittivity, which in turn determine the changing magnitude and direction of electric charge作者: AWL 時(shí)間: 2025-3-25 23:18
Biophysical Effects of Tumor Treating Fields, in and around the quiescent and dividing cell due to the application of an AC field with a frequency in this intermediate region. Our results confirmed several predicted outcomes of TTField application. During metaphase a nonzero intracellular field strength .. is induced in the cell. The frequency作者: 一大塊 時(shí)間: 2025-3-26 03:31 作者: aquatic 時(shí)間: 2025-3-26 06:10 作者: 交響樂 時(shí)間: 2025-3-26 11:44
Clinical Efficacy of Tumor Treating Fields for Recurrent Glioblastoma,with the device were grade 1 or 2 scalp dermatitis, and shifting of the arrays slightly during array change and applying topical corticosteroid can minimize this irritation. There were far less hematological and gastrointestinal toxicities when compared to chemotherapy. In . analyses of EF-11, secon作者: atopic 時(shí)間: 2025-3-26 14:36 作者: 廚房里面 時(shí)間: 2025-3-26 17:30
Tumor Treating Fields Therapy for Newly Diagnosed Glioblastoma,ds together with maintenance temozolomide when compared to those treated with temozolomide alone. The median progression free survival was 7.1 (95 % CI 5.9–8.2) months in the TTFields plus temozolomide cohort and 4.0 (95 % CI 3.3–5.2) months in the temozolomide alone cohort (hazard ratio = 0.62 [95 作者: jet-lag 時(shí)間: 2025-3-26 23:45 作者: Affluence 時(shí)間: 2025-3-27 02:13
Future Directions for Tumor Treating Fields,1 trial for non-small cell lung cancer brain metastasis is currently recruiting subjects in Europe and the METIS or EF-25 trial is now open in the United States. These studies will provide efficacy data on TTFields for other types of central nervous system tumors. Lastly, extracranial application of作者: Enthralling 時(shí)間: 2025-3-27 06:49
cies.Written for a broad audience that includes clinicians, .This concise text provides acomplete overview of alternating electric fields therapy -- also known as tumortreating fields -- for glioblastoma and other types of solid tumormalignancies. Readers are given a fundamental understanding of thi作者: 網(wǎng)絡(luò)添麻煩 時(shí)間: 2025-3-27 11:29 作者: Thyroxine 時(shí)間: 2025-3-27 16:41 作者: evaculate 時(shí)間: 2025-3-27 19:51
http://image.papertrans.cn/a/image/154023.jpg作者: CLAM 時(shí)間: 2025-3-28 00:16
Konstruktionsschritt 2: Testkonstruktion normally through metaphase but exhibit uncontrolled membrane blebbing at the onset of anaphase, resulting in aberrant mitotic exit. The ability of TTFields to affect mitosis is likely dependent on their interactions with proteins possessing high dipole moments whose function is critical to mitosis.作者: Picks-Disease 時(shí)間: 2025-3-28 03:52
https://doi.org/10.1007/978-3-658-10681-2. Recently, the anticancer Tumor Treating Fields (TTFields), which are alternating electric fields applied according to the principles of Maxwell’s equations of electromagnetism, has made available a novel method of treating patients with glioblastomas, brain metastases, and certain systemic maligna作者: Digest 時(shí)間: 2025-3-28 09:18
Konstruktionsschritt 3: Scoring theoretical investigations lead to numerous cell characterization and manipulation techniques which were translated into clinical applications. Low-frequency alternating current (AC) fields are employed for nerve and muscle stimulation, while high-frequency fields find medical relevance in tissue h作者: 秘密會(huì)議 時(shí)間: 2025-3-28 13:59 作者: noxious 時(shí)間: 2025-3-28 16:57 作者: GRATE 時(shí)間: 2025-3-28 21:04 作者: 得意牛 時(shí)間: 2025-3-29 01:09 作者: 堅(jiān)毅 時(shí)間: 2025-3-29 05:15 作者: DAMN 時(shí)間: 2025-3-29 08:26
,Formver?nderung der H?nde und Fü?e,g irritant or allergic contact dermatitis, erosions due to mechanical trauma or moisture, ulcers, and cutaneous infections may develop on the scalp where the transducer arrays are applied. Prevention of dermatologic adverse events is strongly encouraged through various measures such as meticulous ca作者: 惡臭 時(shí)間: 2025-3-29 14:39 作者: 蛤肉 時(shí)間: 2025-3-29 18:31 作者: 棲息地 時(shí)間: 2025-3-29 20:06 作者: DEBT 時(shí)間: 2025-3-30 03:00 作者: synovium 時(shí)間: 2025-3-30 06:55
Caroline A. Hébert,Joffre B. Bakert a strong influence on the pattern of atmospheric circulation, and on the advective heat and moisture fluxes. Numerous lakes and extensive wetlands affect surface energy and water balances through evaporation enhancement. Snow, ice (river and lake), and frost are major land surface features molded
